December 31, 2021

December 31, 2021

ASH 2020: Professor Michael Hallek Discusses Results of a Study on the Impact on Overall Survival of Severe Infections in CLL/SLL Patients Who Received Chemoimmunotherapy (CIT)

In this video, Professor Michael Hallek, M.D., the Director of the Center for Integrated Oncology (CIO) at the University of Cologne, Germany, and the head of the German CLL Study Group (GCLLSG) is interviewed by CLL Society founder and Chief Medical Officer, Dr. Brian Koffman, M.D., a retired family

December 31, 2021

ASH 2021: A Comparative Analysis of Patient Experience and Patient-Doctor Communication in Patients with Lymphoma and CLL/SLL: Clinical Trials Versus Non-Clinical Trials

Communication is critical among patients, caregivers, and doctors to optimize the understanding of treatment options, risks, benefits, compliance, success, and recognition of adverse reactions.

December 31, 2021

Use of Early Remdesivir to Prevent Progression of COVID-19 to Severe Disease When Given in the Outpatient Setting

The best plan is not to get COVID-19 but IV remdesivir may be the best and only option for combatting Omicron for several weeks until we have easy access to the new treatments and to Evusheld for prevention.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

December 31, 2021

ASH 2020: Professor Michael Hallek Discusses Results of a Study on the Impact on Overall Survival of Severe Infections in CLL/SLL Patients Who Received Chemoimmunotherapy (CIT)

ASH 2021: A Comparative Analysis of Patient Experience and Patient-Doctor Communication in Patients with Lymphoma and CLL/SLL: Clinical Trials Versus Non-Clinical Trials

Use of Early Remdesivir to Prevent Progression of COVID-19 to Severe Disease When Given in the Outpatient Setting

CLL SOCIETY FAST FIND

QUICK LINKS

ABOUT US

CONTACT